Clinical Trials Directory

Trials / Conditions / Stage I Breast Cancer

Stage I Breast Cancer

56 registered clinical trials studyying Stage I Breast Cancer7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingMindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
NCT06811454
Case Comprehensive Cancer CenterN/A
RecruitingA Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
NCT07095114
Barbara Ann Karmanos Cancer InstituteN/A
RecruitingA Study of Revaree Plus in People With Breast Cancer
NCT07042581
Memorial Sloan Kettering Cancer CenterPhase 4
RecruitingTeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Pat
NCT05535192
Dana-Farber Cancer InstituteN/A
RecruitingImproving Exercise Capacity With a Tailored Physical Activity Intervention
NCT05595577
Wake Forest University Health SciencesN/A
CompletedTo Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study)
NCT05727813
University of Roma La SapienzaN/A
WithdrawnPartial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer
NCT05436808
Stony Brook UniversityEARLY_Phase 1
RecruitingComparison Between Prepectoral and Subpectoral Breast Reconstruction
NCT05833659
Beijing Friendship Hospital
Active Not RecruitingSingle Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiatio
NCT04849871
Washington University School of MedicineN/A
RecruitingDe-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less
NCT04852887
NRG OncologyPhase 3
Active Not RecruitingHypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.
NCT05318274
Coordinación de Investigación en Salud, MexicoN/A
Active Not RecruitingNiraparib + Dostarlimab In BRCA Mutated Breast Cancer
NCT04584255
Dana-Farber Cancer InstitutePhase 2
Active Not RecruitingResearching the Effect of Exercise on Cancer
NCT04589468
Memorial Sloan Kettering Cancer CenterN/A
TerminatedOmission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete
NCT04578106
Fundacio Clinic BarcelonaPhase 2
WithdrawnExercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Can
NCT03091842
University of Southern CaliforniaN/A
Active Not RecruitingAcupuncture Pilot Study for Cancer-related Cognitive Function
NCT04007770
Memorial Sloan Kettering Cancer CenterPhase 2
CompletedLiving Well After Breast Surgery
NCT03834532
University of Texas at AustinN/A
UnknownBiomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer
NCT03691311
Institut Català d'OncologiaEARLY_Phase 1
CompletedHypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer
NCT03345420
University of UtahPhase 2
TerminatedExercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
NCT03284346
University of Southern CaliforniaN/A
TerminatedCopanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage
NCT03128619
Jonsson Comprehensive Cancer CenterPhase 1
CompletedStudy of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
NCT03113825
Avelas Biosciences, Inc.Phase 2
CompletedUltrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer
NCT03139435
Wake Forest University Health SciencesN/A
CompletedWeb-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering
NCT03061175
Rutgers, The State University of New JerseyN/A
CompletedCarevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
NCT03198286
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityN/A
CompletedComparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patient
NCT02419807
Case Comprehensive Cancer CenterN/A
CompletedEffects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer
NCT02370277
University of Southern California
Active Not RecruitingEnergy Balance and Breast Cancer Aspects-II
NCT02240836
Oslo University HospitalN/A
CompletedA Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
NCT02129686
Dana-Farber Cancer InstituteN/A
TerminatedDetection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
NCT02096588
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
CompletedExtended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Pro
NCT03233555
Rutgers, The State University of New JerseyN/A
TerminatedRadiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
NCT01754519
Roswell Park Cancer InstitutePhase 2
TerminatedFeasibility of a Supportive Education Program for Latina Breast Cancer Survivors
NCT01628887
City of Hope Medical CenterN/A
CompletedExercise Program for Early Breast Cancer Survivors
NCT01140282
University of Southern CaliforniaN/A
TerminatedA Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer
NCT01194427
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
CompletedZoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
NCT01194440
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
TerminatedEntinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery
NCT01234532
University of Maryland, BaltimorePhase 2
CompletedBreast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors
NCT01113554
Wake Forest University Health SciencesN/A
CompletedAlkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy
NCT01487954
Case Comprehensive Cancer CenterPhase 2
WithdrawnBreast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer
NCT01100489
Case Comprehensive Cancer CenterPhase 2
TerminatedRosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Ca
NCT01051401
Wake Forest University Health SciencesPhase 1
TerminatedAcupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Rece
NCT01050075
City of Hope Medical CenterN/A
CompletedMUC1 Vaccine for Triple-negative Breast Cancer
NCT00986609
Joseph Baar, MD, PhDEARLY_Phase 1
CompletedAcupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Rela
NCT01013337
Abramson Cancer Center at Penn MedicineN/A
CompletedDefined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer
NCT00516243
National Cancer Institute (NCI)Phase 1
CompletedVitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole
NCT00416715
University of WashingtonPhase 2
CompletedBilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breas
NCT01043003
City of Hope Medical CenterN/A
UnknownPartial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
NCT00337064
University of VermontPhase 1 / Phase 2
CompletedDexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in
NCT00343863
University of WashingtonN/A
CompletedVorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer
NCT00262834
National Cancer Institute (NCI)Phase 2
TerminatedHormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA B
NCT00194792
University of WashingtonPhase 2
TerminatedCapecitabine in Women With Operable Breast Cancer
NCT00148720
Dana-Farber Cancer InstitutePhase 2
CompletedPegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
NCT00146562
Harold J. Burstein, MD, PhDPhase 2
CompletedCelecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
NCT00070057
National Cancer Institute (NCI)Phase 1
CompletedCytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
NCT00146588
Craig A. Bunnell, MD, MPHN/A
TerminatedFactors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
NCT00019643
National Institutes of Health Clinical Center (CC)